During postnatal development, microglia, the resident innate immune cells of the central nervous system are constantly monitoring the brain parenchyma, cleaning the cell debris, the synaptic contacts overproduced and also maintaining the brain homeostasis. In this context, the postnatal microglia need some control over the innate immune response. One such molecule recently described to be involved in modulation of immune response is TREM2 (triggering receptor expressed on myeloid cells 2). Although some studies have observed TREM2 mRNA in postnatal brain, the regional pattern of the TREM2 protein has not been described. We therefore characterized the distribution of TREM2 protein in mice brain from Postnatal day (P) 1 to 14 by immunostaining. In our study, TREM2 protein was expressed only in microglia/macrophages and is developmentally downregulated in a region-dependent manner. Its expression persisted in white matter, mainly in caudal corpus callosum, and the neurogenic subventricular zone for a longer time than in grey matter. Additionally, the phenotypes of the TREM2+ microglia also differ; expressing CD16/32, MHCII and CD86 (antigen presentation markers) and CD68 (phagocytic marker) in different regions as well as with different intensity till P7. The mannose receptor (CD206) colocalized with TREM2 only at P1–P3 in the subventricular zone and cingulum, while others persisted at low intensities till P7. Furthermore, the spatiotemporal expression pattern and characterization of TREM2 indicate towards its other plausible roles in phagocytosis, progenitor’s fate determination or microglia phenotype modulation during postnatal development. Hence, the increase of TREM2 observed in pathologies may recapitulate their function during postnatal development, as a better understanding of this period may open new pathway for future therapies.
References
[1]
Cuadros MA, Martin C, Coltey P, Almendros A, Navascues J (1993) First appearance, distribution, and origin of macrophages in the early development of the avian central nervous system. J Comp Neurol 330: 113–129.
[2]
Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, et al. (2012) A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336: 86–90.
[3]
Navascues J, Calvente R, Marin-Teva JL, Cuadros MA (2000) Entry, dispersion and differentiation of microglia in the developing central nervous system. An Acad Bras Cienc 72: 91–102.
[4]
Dalmau I, Vela JM, Gonzalez B, Finsen B, Castellano B (2003) Dynamics of microglia in the developing rat brain. J Comp Neurol 458: 144–157.
[5]
Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, et al. (2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330: 841–845.
[6]
Alliot F, Godin I, Pessac B (1999) Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res Dev Brain Res 117: 145–152.
[7]
Dalmau I, Finsen B, Zimmer J, Gonzalez B, Castellano B (1998) Development of microglia in the postnatal rat hippocampus. Hippocampus 8: 458–474.
[8]
Hristova M, Cuthill D, Zbarsky V, Acosta-Saltos A, Wallace A, et al. (2010) Activation and deactivation of periventricular white matter phagocytes during postnatal mouse development. Glia 58: 11–39.
[9]
Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308: 1314–1318.
[10]
Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, et al. (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8: 752–758.
[11]
Tremblay M-è, Stevens B, Sierra A, Wake H, Bessis A, et al. (2011) The role of microglia in the healthy brain. The Journal of neuroscience : the official journal of the Society for Neuroscience 31: 16064–16073.
[12]
Ekdahl CT (2012) Microglial activation - tuning and pruning adult neurogenesis. Front Pharmacol 3: 41.
[13]
Wake H, Moorhouse AJ, Miyamoto A, Nabekura J (2013) Microglia: actively surveying and shaping neuronal circuit structure and function. Trends Neurosci 36: 209–217.
[14]
Perry VH, Hume DA, Gordon S (1985) Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience 15: 313–326.
[15]
Ransohoff RM, Cardona AE (2010) The myeloid cells of the central nervous system parenchyma. Nature 468: 253–262.
[16]
Ransohoff R, Perry V (2009) Microglial physiology: unique stimuli, specialized responses. Annual review of immunology 27: 119–164.
[17]
Colton C (2009) Heterogeneity of microglial activation in the innate immune response in the brain. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 4: 399–418.
[18]
Kettenmann H, Hanisch U-K, Noda M, Verkhratsky A (2011) Physiology of microglia. Physiological reviews 91: 461–1014.
[19]
Tambuyzer BR, Ponsaerts P, Nouwen EJ (2009) Microglia: gatekeepers of central nervous system immunology. J Leukoc Biol 85: 352–370.
[20]
Lyons A, Lynch AM, Downer EJ, Hanley R, O’Sullivan JB, et al. (2009) Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attentuates microglial activation in vivo and in vitro. J Neurochem 110: 1547–1556.
[21]
Barclay AN, Wright GJ, Brooke G, Brown MH (2002) CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol 23: 285–290.
[22]
Hoek RM, Ruuls SR, Murphy CA, Wright GJ, Goddard R, et al. (2000) Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290: 1768–1771.
[23]
Shrivastava K, Gonzalez P, Acarin L (2012) The immune inhibitory complex CD200/CD200R is developmentally regulated in the mouse brain. The Journal of comparative neurology 520: 2657–2675.
[24]
van Beek EM, Cochrane F, Barclay AN, van den Berg TK (2005) Signal regulatory proteins in the immune system. J Immunol 175: 7781–7787.
[25]
Stefano L, Racchetti G, Bianco F, Passini N, Gupta R, et al. (2009) The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor. Journal of neurochemistry 110: 284–378.
[26]
Schmid CD, Sautkulis LN, Danielson PE, Cooper J, Hasel KW, et al. (2002) Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia. J Neurochem 83: 1309–1320.
[27]
Thrash J, Torbett B, Carson M (2009) Developmental regulation of TREM2 and DAP12 expression in the murine CNS: implications for Nasu-Hakola disease. Neurochemical research 34: 38–83.
[28]
Colonna M (2003) TREMs in the immune system and beyond. Nat Rev Immunol 3: 445–453.
[29]
Colonna M, Turnbull I, Klesney-Tait J (2007) The enigmatic function of TREM-2 in osteoclastogenesis. Adv Exp Med Biol 602: 97–105.
[30]
Bouchon A, Hernández-Munain C, Cella M, Colonna M (2001) A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. The Journal of experimental medicine 194: 1111–1133.
[31]
Sessa G, Podini P, Mariani M, Meroni A, Spreafico R, et al. (2004) Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia. Eur J Neurosci 20: 2617–2628.
[32]
Kaifu T, Nakahara J, Inui M, Mishima K, Momiyama T, et al. (2003) Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest 111: 323–332.
[33]
Kiialainen A, Hovanes K, Paloneva J, Kopra O, Peltonen L (2005) Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS. Neurobiol Dis 18: 314–322.
[34]
Wakselman S, Béchade C, Roumier A, Bernard D, Triller A, et al. (2008) Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor. The Journal of neuroscience : the official journal of the Society for Neuroscience 28: 8138–8181.
[35]
Roumier A, Béchade C, Poncer J-C, Smalla K-H, Tomasello E, et al. (2004) Impaired synaptic function in the microglial KARAP/DAP12-deficient mouse. The Journal of neuroscience : the official journal of the Society for Neuroscience 24: 11421–11429.
[36]
Paloneva J, Autti T, Raininko R, Partanen J, Salonen O, et al. (2001) CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts. Neurology 56: 1552–1558.
[37]
Paloneva J, Manninen T, Christman G, Hovanes K, Mandelin J, et al. (2002) Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am J Hum Genet 71: 656–662.
[38]
Derecki NC, Cronk JC, Kipnis J (2013) The role of microglia in brain maintenance: implications for Rett syndrome. Trends Immunol 34: 144–150.
[39]
Derecki NC, Cronk JC, Lu Z, Xu E, Abbott SB, et al. (2012) Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484: 105–109.
[40]
Turnbull IR, Gilfillan S, Cella M, Aoshi T, Miller M, et al. (2006) Cutting edge: TREM-2 attenuates macrophage activation. J Immunol 177: 3520–3524.
[41]
Takahashi K, Rochford C, Neumann H (2005) Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. The Journal of experimental medicine 201: 647–704.
[42]
Piccio L, Buonsanti C, Mariani M, Cella M, Gilfillan S, et al. (2007) Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. European journal of immunology 37: 1290–1591.
[43]
Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H (2007) TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med 4: e124.
[44]
Sieber MW, Jaenisch N, Brehm M, Guenther M, Linnartz-Gerlach B, et al. (2013) Attenuated inflammatory response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice following stroke. PLoS One 8: e52982.
[45]
Paxinos G, Halliday G, Watson C, Koutcherov Y, Wang H (2007) Atlas of the Developing Mouse Brain at E17.5, P0 and P6.; Inc. E, editor. London: Academic Press.
[46]
Shrivastava K, Chertoff M, Llovera G, Recasens M, Acarin L (2012) Short and long-term analysis and comparison of neurodegeneration and inflammatory cell response in the ipsilateral and contralateral hemisphere of the neonatal mouse brain after hypoxia/ischemia. Neurol Res Int 2012: 781512.
[47]
Zhao Y, Bhattacharjee S, Jones BM, Dua P, Alexandrov PN, et al. (2013) Regulation of TREM2 expression by an NF-small ka, CyrillicB-sensitive miRNA-34a. Neuroreport 24: 318–323.
[48]
Prada I, Ongania G, Buonsanti C, Panina-Bordignon P, Meldolesi J (2006) Triggering receptor expressed in myeloid cells 2 (TREM2) trafficking in microglial cells: continuous shuttling to and from the plasma membrane regulated by cell stimulation. Neuroscience 140: 1139–1148.
[49]
Frank S, Burbach G, Bonin M, Walter M, Streit W, et al. (2008) TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia 56: 1438–1485.
[50]
Levison SW, Goldman JE (1993) Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat forebrain. Neuron 10: 201–212.
[51]
Menezes JR, Marins M, Alves JA, Froes MM, Hedin-Pereira C (2002) Cell migration in the postnatal subventricular zone. Braz J Med Biol Res 35: 1411–1421.
[52]
Tanaka J, Toku K, Sakanaka M, Maeda N (1999) Morphological differentiation of microglial cells in culture: involvement of insoluble factors derived from astrocytes. Neurosci Res 34: 207–215.
[53]
Kloss CUA, Kreutzberg GW, Raivich G (1997) Proliferation of ramified microglia on an astrocyte monolayer: Characterization of stimulatory and inhibitory cytokines. J Neurosci Res 49: 248–254.
[54]
Tanaka J, Maeda N (1996) Microglial ramification requires nondiffusible factors derived from astrocytes. Exp Neurol 137: 367–375.
[55]
Milligan CE, Cunningham TJ, Levitt P (1991) Differential immunochemical markers reveal the normal distribution of brain macrophages and microglia in the developing rat brain. Journal of Comparative Neurology 314: 125–135.
[56]
Cuadros MA, Navascues J (1998) The origin and differentiation of microglial cells during development. Prog Neurobiol 56: 173–189.
[57]
Billiards SS, Haynes RL, Folkerth RD, Trachtenberg FL, Liu LG, et al. (2006) Development of microglia in the cerebral white matter of the human fetus and infant. J Comp Neurol 497: 199–208.
[58]
Chhor V, Le Charpentier T, Lebon S, Ore MV, Celador IL, et al.. (2013) Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav Immun.
[59]
Santambrogio L, Belyanskaya S, Fischer F, Cipriani B, Brosnan C, et al. (2001) Developmental plasticity of CNS microglia. Proceedings of the National Academy of Sciences of the United States of America 98: 6295–6300.
[60]
Lawson LJ, Perry VH, Dri P, Gordon S (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39: 151–170.
[61]
Olah M, Biber K, Vinet J, Boddeke HW (2011) Microglia phenotype diversity. CNS Neurol Disord Drug Targets 10: 108–118.
[62]
Kigerl K, Gensel J, Ankeny D, Alexander J, Donnelly D, et al. (2009) Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. The Journal of neuroscience : the official journal of the Society for Neuroscience 29: 13435–13444.
[63]
Hu X, Li P, Guo Y, Wang H, Leak R, et al.. (2012) Microglia/Macrophage Polarization Dynamics Reveal Novel Mechanism of Injury Expansion After Focal Cerebral Ischemia. Stroke; a journal of cerebral circulation.
[64]
Xu Y, Qian L, Zong G, Ma K, Zhu X, et al. (2012) Class A scavenger receptor promotes cerebral ischemic injury by pivoting microglia/macrophage polarization. Neuroscience 218: 35–48.
[65]
Butovsky O, Ziv Y, Schwartz A, Landa G, Talpalar AE, et al. (2006) Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci 31: 149–160.
[66]
Garay PA, Hsiao EY, Patterson PH, McAllister AK (2012) Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development. Brain Behav Immun.
[67]
Bo L, Mork S, Kong PA, Nyland H, Pardo CA, et al. (1994) Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 51: 135–146.
[68]
Suzuki K, Sugihara G, Ouchi Y, Nakamura K, Futatsubashi M, et al. (2013) Microglial activation in young adults with autism spectrum disorder. JAMA Psychiatry 70: 49–58.
[69]
Kato TA, Kanba S (2013) Are microglia minding us? Digging up the unconscious mind-brain relationship from a neuropsychoanalytic approach. Front Hum Neurosci 7: 13.
[70]
Chew LJ, Fusar-Poli P, Schmitz T (2013) Oligodendroglial Alterations and the Role of Microglia in White Matter Injury: Relevance to Schizophrenia. Dev Neurosci.
[71]
Chouery E, Delague V, Bergougnoux A, Koussa S, Serre JL, et al. (2008) Mutations in TREM2 lead to pure early-onset dementia without bone cysts. Hum Mutat 29: E194–204.
[72]
Guerreiro R, Lohmann E, Brás J, Gibbs J, Rohrer J, et al. (2013) Using Exome Sequencing to Reveal Mutations in TREM2 Presenting as a Frontotemporal Dementia-like Syndrome Without Bone Involvement. JAMA neurology 70: 78–84.
[73]
Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, et al. (2013) Variant of TREM2 associated with the risk of Alzheimer’s disease. N Engl J Med 368: 107–116.
[74]
Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, et al. (2013) TREM2 variants in Alzheimer’s disease. N Engl J Med 368: 117–127.
